Paul Moore
0000-0001-6057-7539
3 papers found
Refreshing results…
Interplay between B7–H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma
The PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trial
Development and Preliminary Clinical Activity of PD-1-Guided CTLA-4 Blocking Bispecific DART Molecule
Missing publications? Search for publications with a matching author name.